π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
The purpose of this study is to evaluate the pharmacokinetic study of the c...
Status
Completed
Location
The First Affiliated Hospital of Xi'an Jiaotong University
Start Date
2015-05
Trial ID
NCT02451527
This is a phase I study to evaluate drug-drug interactions (DDIs) of D-1553...
Status
Completed
Location
Shanghai Xuhui District Central Hospital
Start Date
2023-05-24
Trial ID
NCT06105255
Treatments Being Tested
This project will evaluate the effect of gender-affirming testosterone trea...
Status
Completed
Location
University of Washington
Start Date
2021-05-01
Trial ID
NCT05116293
Treatments Being Tested
The purpose of this study is to determine how multiple doses of canaglifloz...
Status
Completed
Location
Multiple Locations
Start Date
2009-06
Trial ID
NCT01714206
Treatments Being Tested
The purpose of this study is to Assess the Effect of Povorcitinib on Digoxi...
Status
Completed
Location
Fortrea Clinical Research Unit
Start Date
2024-06-19
Trial ID
NCT06416800
Treatments Being Tested
Primary: To quantify the influence of single-dose and steady-state tipranav...
Status
Completed
Location
Multiple Locations
Start Date
2006-01
Trial ID
NCT02243553
The purpose of this study is to evaluate the effects of SHR7280 on the phar...
Status
Completed
Location
Zhongnan hospital of Wuhan University
Start Date
2025-04-28
Trial ID
NCT06949124
Treatments Being Tested
To assess the effect of PEX168 doses on the pharmacokinetics of digoxin in ...
Status
Completed
Location
The first affiliate of Xi'an Jiaotong University
Start Date
2015-06-08
Trial ID
NCT02472236
Evaluate the effect of regorafenib on the pharmacokinetics of digoxin (P-gp...
Status
Completed
Location
Multiple Locations
Start Date
2014-04-22
Trial ID
NCT02106845
Treatments Being Tested
The primary purpose of this study is to assess the effect of the Daclatasvi...
Status
Completed
Location
Multiple Locations
Start Date
2014-02
Trial ID
NCT02045966
Treatments Being Tested